Research Medical Center
August 07, 2017

HCA Midwest Health, Kansas City’s leading healthcare and breast healthcare provider, announces that the Breast Center at Sarah Cannon Cancer Institute at Research Medical Center has been granted three-year/full accreditation designations by the National Accreditation Program for Breast Centers (NAPBC), a program administered by the American College of Surgeons.  Three other HCA Midwest Health hospitals, including Centerpoint Medical Center, Menorah Medical Center and Overland Park Regional Medical Center, have also received three-year/full accreditations.

Accreditation by the NAPBC is only given to those breast centers that have voluntarily committed to provide the highest level of quality breast care and that undergo a rigorous evaluation process and review of their performance.  During the survey process, the breast centers must demonstrate compliance with standards established by the NAPBC for treating women who are diagnosed with the full spectrum of breast disease.  The standards include proficiency in the areas of: center leadership, clinical management, research, community outreach, professional education and quality improvement.

“Research Medical Center has been a leader in breast care and breast health for thousands of patients and their families in the Kansas City region for many years,” says Jackie DeSouza-Van Blaricum, Chief Executive Officer, Research Medical Center. “This three-year, full accreditation reflects the commitment and dedication by our world-class physicians, imaging technologists, specialists, nurses and breast nurse navigators. Their collaborative goal is to offer innovative, leading-edge, convenient and compassionate care, from diagnosis to treatment and after care, to patients, helping to ensure best outcomes as they fight breast disease.”

Receiving care at a NAPBC-accredited center ensures that a patient will have access to: comprehensive care, including a full range of state-of-the-art services; a multidisciplinary team approach to coordinate the best treatment options; information about ongoing clinical trials and new treatment options; and, most importantly, quality breast care close to home. 

The American Cancer Society (ACS) estimated that there would be 232,340 patients diagnosed with invasive breast cancer in the United States in 20131. In addition, hundreds of thousands of women who will deal with benign breast disease this year will require medical evaluation for treatment options.

The NAPBC is a consortium of professional organizations dedicated to the improvement of the quality of care and monitoring of outcomes of patients with diseases of the breast.  This mission is pursued through standard-setting, scientific validation, and patient and professional education.  Its board membership includes professionals from 20 national organizations that reflect the full spectrum of breast care. 

For more information about Sarah Cannon Cancer Institute at Research Medical Center and its full spectrum of comprehensive breast care services, including diagnosis, treatment and after care, visit